Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study
Authors:
Open Access
- 22 March 2021
- journal article
- research article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (6) , 1619-1627
Abstract
Blot and colleagues have proposed putative invasive pulmonary aspergillosis (PIPA) definitions for troublesome diagnosis in suspected patients outside the classical criteria of immunosuppression. We retrospectively included in the study all admitted patients with an Aspergillus spp. positive culture within lower airway samples. Overall, Aspergillus spp. positivity in respiratory samples was 0.97 every 1000 hospital admissions (HA): 4.94 and 0.28/1000/HA, respectively, in intensive care units (ICUs) and medical wards (MW). 66.6% fulfilled PIPA criteria, and 33.4% were defined as colonized. 69.2% of PIPA diagnosis occurred in the ICU. Antifungal therapy was appropriate in 88.5% of subjects with PIPA and 37.5% of colonized, confirming the comparison between deads and lives. Patients with PIPA in the ICUs had more frequent COPD, sepsis or septic shock, acute kidney injury (AKI), needed more surgery, mechanical ventilation (MV), vasopressors, hemodialysis, blood or platelets transfusions. PIPA in MW had associated with a history of smoking, interstitial lung disease and inhaled steroid therapy. Overall mortality within 21 days was 50%: 54.2% in ICU, 36,8% in MW. Factors associated with death were length of hospitalization, influenza, pneumonia, liver transplant, AKI, ARDS, sepsis and septic shock. PIPA in the ICU had higher disease severity and needed more organ support than MW cases, despite that cases of PIPA in MW are emerging with trends difficult to demonstrate given the problematic diagnosis.Keywords
Funding Information
- Università degli Studi di Torino
This publication has 20 references indexed in Scilit:
- Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract culturesInternational Journal of Antimicrobial Agents, 2017
- Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomesCritical Care, 2015
- Aspergillus in the lower respiratory tract of immunocompetent critically ill patientsJournal of Infection, 2014
- Identification and management of invasive mycoses in internal medicine: a road-map for physiciansInternal and Emergency Medicine, 2014
- SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patientsInfection, 2013
- Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)Infection, 2013
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: Analysis of a 14-Month Prospective Clinical ExperienceJournal of Chemotherapy, 2011
- Invasive Aspergillosis in Critically Ill Patients without MalignancyAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Disseminated Aspergillosis in Intensive Care Unit Patients: An Autopsy StudyJournal of Chemotherapy, 2003